Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP380335.RAZ6MePyPxzGfYVQG2XNeEs5dbpyMw7nN_-yY5rveiHsI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP380335.RAZ6MePyPxzGfYVQG2XNeEs5dbpyMw7nN_-yY5rveiHsI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP380335.RAZ6MePyPxzGfYVQG2XNeEs5dbpyMw7nN_-yY5rveiHsI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP380335.RAZ6MePyPxzGfYVQG2XNeEs5dbpyMw7nN_-yY5rveiHsI130_provenance.
- NP380335.RAZ6MePyPxzGfYVQG2XNeEs5dbpyMw7nN_-yY5rveiHsI130_assertion description "[Patients with HER2/neu positive malignancies show elevated serum CA15-3 (37.09+/-2.55 IU/ml), as well as patients who developed recurrence (40.75+/-2.11 IU/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380335.RAZ6MePyPxzGfYVQG2XNeEs5dbpyMw7nN_-yY5rveiHsI130_provenance.
- NP380335.RAZ6MePyPxzGfYVQG2XNeEs5dbpyMw7nN_-yY5rveiHsI130_assertion evidence source_evidence_literature NP380335.RAZ6MePyPxzGfYVQG2XNeEs5dbpyMw7nN_-yY5rveiHsI130_provenance.
- NP380335.RAZ6MePyPxzGfYVQG2XNeEs5dbpyMw7nN_-yY5rveiHsI130_assertion SIO_000772 24674678 NP380335.RAZ6MePyPxzGfYVQG2XNeEs5dbpyMw7nN_-yY5rveiHsI130_provenance.
- NP380335.RAZ6MePyPxzGfYVQG2XNeEs5dbpyMw7nN_-yY5rveiHsI130_assertion wasDerivedFrom befree-20150227 NP380335.RAZ6MePyPxzGfYVQG2XNeEs5dbpyMw7nN_-yY5rveiHsI130_provenance.
- NP380335.RAZ6MePyPxzGfYVQG2XNeEs5dbpyMw7nN_-yY5rveiHsI130_assertion wasGeneratedBy ECO_0000203 NP380335.RAZ6MePyPxzGfYVQG2XNeEs5dbpyMw7nN_-yY5rveiHsI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP380335.RAZ6MePyPxzGfYVQG2XNeEs5dbpyMw7nN_-yY5rveiHsI130_provenance.